Alpine Associates Management Inc. Vectiv Bio Holding Ag Transaction History

Alpine Associates Management Inc.

  • $2.17 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$8.29 - $16.97 $15 Million - $30.7 Million
1,806,697 New
1,806,697 $30.5 Million

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0
View Full List

About VectivBio Holding AG

VECT Quotes by TradingView
  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Alpine Associates Management Inc. Portfolio

Follow Alpine Associates Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Associates Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alpine Associates Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email